DF
AZN icon

Dunhill Financial’s AstraZeneca AZN Stock Holding History

Dunhill Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58K Sell
8
-35
-81% -$6.75K ﹤0.01% 858
2025
Q4 		$7.91K Buy
43
+1
+2% +$175 ﹤0.01% 536
2025
Q3 		$6.37K Buy
42
+6
+17% +$908 ﹤0.01% 535
2025
Q2 		$4.97K Buy
36
+4
+13% +$561 ﹤0.01% 547
2025
Q1 		$4.7K Sell
32
-32
-50% -$4.63K ﹤0.01% 580
2024
Q4 		$8.39K Buy
64
+32
+100% +$4.48K ﹤0.01% 428
2024
Q3 		$4.99K Hold
32
– – ﹤0.01% 553
2024
Q2 		$4.99K Hold
32
– – ﹤0.01% 394
2024
Q1 		$4.34K Hold
32
– – ﹤0.01% 344
2023
Q4 		$3.9K Buy
+32
New +$4.16K ﹤0.01% 321

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Dunhill Financial's AZN Position: Q1 2026 in Review

Dunhill Financial reduced its AstraZeneca (AZN) stake by 81% in Q1 2026, selling an estimated $6.75K and leaving 8 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Dunhill Financial first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.39K in Q4 2024. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Dunhill Financial held 8 shares of AstraZeneca worth $1.58K as of Q1 2026.
  • Dunhill Financial sold 35 AstraZeneca shares in Q1 2026, an estimated $6.75K.
  • AstraZeneca made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #858 holding.
  • Dunhill Financial first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's AstraZeneca position peaked at $8.39K in Q4 2024.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.